Fig. 7From: Extracellular vesicle-encapsulated miR-22-3p from bone marrow mesenchymal stem cell promotes osteogenic differentiation via FTO inhibitionMechanism, miR-22-3p encapsulated in BMSCs-derived EVs inhibits MYC/PI3K/AKT pathway and promotes osteogenic differentiation by targeting FTOBack to article page